scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Andreas Weigert | Q48297787 |
P2093 | author name string | Bernhard Brüne | |
Catherine Olesch | |||
P2860 | cites work | Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-alpha signaling | Q24292094 |
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2 | Q24336131 | ||
Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities | Q24617969 | ||
Exploring the full spectrum of macrophage activation | Q24653754 | ||
Tissue-specific contribution of macrophages to wound healing | Q26741570 | ||
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential | Q26766425 | ||
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applications | Q26779667 | ||
Macrophages in intestinal homeostasis and inflammation | Q26851960 | ||
Sphingosine 1-phosphate signalling | Q26852942 | ||
Sphingolipid signaling in metabolic disorders | Q26992148 | ||
Macrophages: gatekeepers of tissue integrity | Q27007092 | ||
Macrophage polarization in health and disease | Q27027054 | ||
Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M | Q27667968 | ||
S1PR5 is pivotal for the homeostasis of patrolling monocytes. | Q52639389 | ||
Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction. | Q52666785 | ||
Sphingosine-1-phosphate receptors and innate immunity. | Q52677659 | ||
Sphingosine-1-phosphate receptor 1 mediates elevated IL-6 signaling to promote chronic inflammation and multitissue damage in sickle cell disease. | Q52699536 | ||
Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4. | Q53269844 | ||
FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. | Q53575759 | ||
Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2. | Q54119596 | ||
Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. | Q54548267 | ||
S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. | Q54611404 | ||
LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. | Q54976698 | ||
A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. | Q55001442 | ||
Mapping macrophage polarization over the myocardial infarction time continuum. | Q55234249 | ||
Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages. | Q55249743 | ||
Sphingolipids and Innate Immunity: A New Approach to Infection in the Post-Antibiotic Era? | Q57050718 | ||
Sphingosine 1-phosphate receptor subtype 3 (S1P) contributes to brain injury after transient focal cerebral ischemia via modulating microglial activation and their M1 polarization | Q57284831 | ||
Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria | Q57369563 | ||
The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages | Q58730196 | ||
Macrophages: friend or foe in idiopathic pulmonary fibrosis? | Q58761750 | ||
Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages | Q58768213 | ||
Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes | Q59134951 | ||
Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis | Q60947050 | ||
A Macrophage-Pericyte Axis Directs Tissue Restoration via Amphiregulin-Induced Transforming Growth Factor Beta Activation | Q64076022 | ||
Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells | Q79259664 | ||
Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice | Q80022540 | ||
Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences | Q81880357 | ||
The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6 | Q84596461 | ||
Sphingosine-1-phospate receptor 4 (S1P₄) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model | Q84719235 | ||
The human heart contains distinct macrophage subsets with divergent origins and functions | Q89070227 | ||
Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury | Q90632741 | ||
Potent anti-inflammatory properties of HDL in vascular smooth muscle cells mediated by HDL-S1P and their impairment in coronary artery disease due to lower HDL-S1P: a new aspect of HDL dysfunction and its therapy | Q91063288 | ||
Regulation of ABCA1-mediated cholesterol efflux by sphingosine-1-phosphate signaling in macrophages | Q91098582 | ||
Sphingosine 1-Phosphate (S1P)/S1P Receptor2/3 Axis Promotes Inflammatory M1 Polarization of Bone Marrow-Derived Monocyte/Macrophage via G(α)i/o/PI3K/JNK Pathway | Q91545988 | ||
Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches | Q92370531 | ||
Pro-Inflammatory Role of S1P3 in Macrophages | Q92655281 | ||
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Q27860475 | ||
Inflammation and cancer: back to Virchow? | Q28036756 | ||
Immunometabolic circuits in trained immunity | Q28066501 | ||
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells | Q28119154 | ||
Cutting edge: Mycobacterium tuberculosis blocks Ca2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase | Q28181855 | ||
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection | Q28235893 | ||
Principles of bioactive lipid signalling: lessons from sphingolipids | Q28265743 | ||
Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization | Q28293429 | ||
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses | Q28303437 | ||
Identification of a unique TGF-β-dependent molecular and functional signature in microglia | Q28303557 | ||
Mass spectrometry imaging of biomarker lipids for phagocytosis and signalling during focal cerebral ischaemia | Q28397015 | ||
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | Q28544407 | ||
The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
Macrophage biology in development, homeostasis and disease | Q29620350 | ||
Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis | Q30278005 | ||
Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. | Q30359883 | ||
The promotion of mandibular defect healing by the targeting of S1P receptors and the recruitment of alternatively activated macrophages | Q30409209 | ||
Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury | Q30432124 | ||
Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages | Q30436091 | ||
Human and rat alveolar macrophages express multiple EDG receptors | Q30665132 | ||
Heme-mediated SPI-C induction promotes monocyte differentiation into iron-recycling macrophages | Q33570011 | ||
Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages | Q33586246 | ||
Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. | Q33773569 | ||
Translational regulation of specific mRNAs controls feedback inhibition and survival during macrophage activation | Q33778581 | ||
Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. | Q33796082 | ||
Role of host sphingosine kinase 1 in the lung response against Cryptococcosis | Q33825994 | ||
The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b | Q33882871 | ||
An update on the biology of sphingosine 1-phosphate receptors. | Q33945064 | ||
Tissue-specific signals control reversible program of localization and functional polarization of macrophages | Q34065482 | ||
Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis | Q34140190 | ||
Sphingosine Kinase 1 expression in peritoneal macrophages is required for colon carcinogenesis | Q47447095 | ||
Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration | Q47806925 | ||
S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. | Q48259591 | ||
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β. | Q48355741 | ||
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors | Q48425484 | ||
Induction of the nuclear receptor PPAR-γ by the cytokine GM-CSF is critical for the differentiation of fetal monocytes into alveolar macrophages. | Q48509512 | ||
The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages. | Q49393104 | ||
Pro-phagocytic Effects of Thymoquinone on Cigarette Smoke-exposed Macrophages Occur by Modulation of the Sphingosine-1-phosphate Signalling System | Q50856270 | ||
High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression | Q50981100 | ||
Macrophages Facilitate Electrical Conduction in the Heart. | Q51041551 | ||
Reduced DNA methylation of sphingosine-1 phosphate receptor 5 in alveolar macrophages in COPD: A potential link to failed efferocytosis | Q51055815 | ||
Understanding the tumor immune microenvironment (TIME) for effective therapy. | Q52311744 | ||
Sphingosine-1-phosphate Receptor 2 Signaling Promotes Caspase-11-dependent Macrophage Pyroptosis and Worsens Escherichia coli Sepsis Outcome. | Q52605011 | ||
Differential S1P Receptor Profiles on M1- and M2-Polarized Macrophages Affect Macrophage Cytokine Production and Migration. | Q37711740 | ||
Sphingolipids Are Dual Specific Drug Targets for the Management of Pulmonary Infections: Perspective | Q37834436 | ||
S1P regulation of macrophage functions in the context of cancer | Q37894771 | ||
Transcriptional regulation of macrophage polarization: enabling diversity with identity | Q37949245 | ||
Sphingosine 1-phosphate signalling in cancer | Q37977171 | ||
The immunology of fibrosis | Q38091697 | ||
Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
HDL in innate and adaptive immunity. | Q38220759 | ||
Origin and functions of tissue macrophages. | Q38230878 | ||
Homeostasis in the mononuclear phagocyte system | Q38232291 | ||
Inflammasome-independent regulation of IL-1-family cytokines | Q38286016 | ||
Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. | Q38340109 | ||
Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation | Q38605015 | ||
S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1β or Lipocalin-2. | Q38626918 | ||
Sphingosine 1-Phosphate and Atherosclerosis. | Q38654911 | ||
Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk | Q38712433 | ||
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model. | Q38752760 | ||
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances | Q38771485 | ||
Phagocytosis: An Immunobiologic Process | Q38776882 | ||
Sphingosine Kinases: Emerging Structure-Function Insights | Q38791678 | ||
Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance. | Q38794549 | ||
Fingolimod provides long-term protection in rodent models of cerebral ischemia | Q38806688 | ||
Resveratrol exerts a biphasic effect on apolipoprotein M. | Q38829760 | ||
Macrophage NOS2 in Tumor Leukocytes | Q38843508 | ||
Recent advances in the development of sphingosine kinase inhibitors | Q38864118 | ||
Sphingolipids in viral infection | Q38926960 | ||
Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages | Q38981282 | ||
Transcriptional control of monocyte and macrophage development | Q39221646 | ||
Does niche competition determine the origin of tissue-resident macrophages? | Q39276574 | ||
Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy | Q39280710 | ||
Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei | Q39385841 | ||
The immune contexture in cancer prognosis and treatment | Q39456999 | ||
Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. | Q39568139 | ||
Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. | Q39758728 | ||
Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages | Q39907854 | ||
Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal | Q36804936 | ||
Trophic macrophages in development and disease | Q36829147 | ||
Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway | Q36854286 | ||
Chop Deficiency Protects Mice Against Bleomycin-induced Pulmonary Fibrosis by Attenuating M2 Macrophage Production | Q36939776 | ||
Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities | Q37010333 | ||
The alliance of sphingosine-1-phosphate and its receptors in immunity | Q37010807 | ||
Redox control of inflammation in macrophages | Q37032282 | ||
The vascular S1P gradient-cellular sources and biological significance | Q37085319 | ||
Sphingosine kinases are not required for inflammatory responses in macrophages | Q37289270 | ||
Specification of tissue-resident macrophages during organogenesis. | Q37343167 | ||
Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis | Q37362062 | ||
Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice. | Q37443636 | ||
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. | Q37454105 | ||
Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery | Q37551932 | ||
Regulation of macrophage function by sphingosine-1-phosphate. | Q37558824 | ||
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. | Q37686404 | ||
Downregulation of sphingosine kinase-1 induces protective tumor immunity by promoting M1 macrophage response in melanoma | Q37687730 | ||
Role of lipids in killing mycobacteria by macrophages: evidence for NF-kappaB-dependent and -independent killing induced by different lipids. | Q39915135 | ||
Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. | Q39992138 | ||
Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages | Q40029162 | ||
Cigarette smoke inhibits efferocytosis via deregulation of sphingosine kinase signaling: reversal with exogenous S1P and the S1P analogue FTY720. | Q40080527 | ||
A Liver Capsular Network of Monocyte-Derived Macrophages Restricts Hepatic Dissemination of Intraperitoneal Bacteria by Neutrophil Recruitment | Q40081249 | ||
Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. | Q40102693 | ||
Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. | Q40104489 | ||
S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population. | Q40279381 | ||
Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. | Q40280838 | ||
Sphingosine 1-phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense against Sepsis | Q41096093 | ||
Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis | Q41570690 | ||
Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. | Q41782419 | ||
Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. | Q42142782 | ||
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. | Q42513727 | ||
The transcription factor Gata6 links tissue macrophage phenotype and proliferative renewal | Q42744709 | ||
The Origin and Maturity of Dendritic Cells Determine the Pattern of Sphingosine 1-Phosphate Receptors Expressed and Required for Efficient Migration | Q42913146 | ||
Brown-adipose-tissue macrophages control tissue innervation and homeostatic energy expenditure | Q43062138 | ||
Editorial: The Cell Types of Fibrosis | Q43075060 | ||
Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease | Q43138779 | ||
S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. | Q43196159 | ||
The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia | Q43283062 | ||
Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis | Q43432914 | ||
FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats | Q44062977 | ||
Sphingosine-1-phosphate signalling induces the production of Lcn-2 by macrophages to promote kidney regeneration | Q44125780 | ||
Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair | Q44163378 | ||
Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages | Q44371529 | ||
Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. | Q44524146 | ||
Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice | Q44777835 | ||
The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis | Q44892426 | ||
Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo | Q44896089 | ||
Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages | Q44907208 | ||
Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis | Q45304872 | ||
KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice | Q45405428 | ||
The role of TRKA signaling in IL-10 production by apoptotic tumor cell-activated macrophages | Q45720263 | ||
The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. | Q45956195 | ||
Lipids regulate P2X7-receptor-dependent actin assembly by phagosomes via ADP translocation and ATP synthesis in the phagosome lumen | Q46143631 | ||
Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation | Q46143632 | ||
S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis. | Q46315054 | ||
Tissue-Resident Macrophages Are Locally Programmed for Silent Clearance of Apoptotic Cells | Q46342472 | ||
Defects of High-Density Lipoproteins in Coronary Artery Disease Caused by Low Sphingosine-1-Phosphate Content: Correction by Sphingosine-1-Phosphate-Loading | Q46377068 | ||
Delivery of monocyte lineage cells in a biomimetic scaffold enhances tissue repair | Q46489164 | ||
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences | Q46516651 | ||
Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis | Q46622055 | ||
Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression | Q46820182 | ||
A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma | Q46979728 | ||
TAMeless traitors: macrophages in cancer progression and metastasis | Q47096116 | ||
Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke. | Q47106944 | ||
Disrupted epithelial/macrophage crosstalk via Spinster homologue 2-mediated S1P signaling may drive defective macrophage phagocytic function in COPD. | Q47112426 | ||
Sphingosine Kinase 1 Regulates Inflammation and Contributes to Acute Lung Injury in Pneumococcal Pneumonia via the Sphingosine-1-Phosphate Receptor 2. | Q47214403 | ||
Sinusoidal protection by sphingosine-1-phosphate receptor 1 agonist in liver ischemia-reperfusion injury | Q47259871 | ||
Extracellular and Intracellular Actions of Sphingosine-1-Phosphate | Q34183703 | ||
Human dermal CD14⁺ cells are a transient population of monocyte-derived macrophages | Q34244161 | ||
Cooperative prosurvival activity by ERK and Akt in human alveolar macrophages is dependent on high levels of acid ceramidase activity | Q34328383 | ||
Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond | Q34364844 | ||
Macrophages in atherosclerosis: a dynamic balance. | Q34368005 | ||
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo | Q34420830 | ||
Environment drives selection and function of enhancers controlling tissue-specific macrophage identities | Q34452301 | ||
Macrophages in Tissue Repair, Regeneration, and Fibrosis | Q34518415 | ||
Immune surveillance of tumors | Q34579196 | ||
Abandoning M1/M2 for a Network Model of Macrophage Function | Q34677978 | ||
Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? | Q34691487 | ||
Lysophospholipid regulation of mononuclear phagocytes | Q34691518 | ||
Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. | Q34748080 | ||
Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff | Q34787221 | ||
A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors | Q34809705 | ||
The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors | Q34901297 | ||
Sphingolipids in pulmonary fibrosis | Q34921823 | ||
Posttranslational modification of Sirt6 activity by peroxynitrite | Q35118010 | ||
Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages | Q35118828 | ||
High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists | Q35238369 | ||
Myocardial infarction: a critical role of macrophages in cardiac remodeling | Q35291097 | ||
Metchnikoff's policemen: macrophages in development, homeostasis and regeneration | Q35577477 | ||
Sphingosine-1-phosphate signaling and its role in disease | Q35661485 | ||
Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD). | Q35814901 | ||
Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. | Q35898425 | ||
C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages | Q35985763 | ||
Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice | Q36012100 | ||
The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium. | Q36211058 | ||
Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning. | Q36561924 | ||
Legionella pneumophila S1P-lyase targets host sphingolipid metabolism and restrains autophagy | Q36607525 | ||
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Q36627430 | ||
Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer | Q36748690 | ||
The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosis | Q36790267 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | macrophage | Q184204 |
P304 | page(s) | 1706 | |
P577 | publication date | 2019-07-19 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Sphingosine-1-Phosphate and Macrophage Biology-How the Sphinx Tames the Big Eater | |
P478 | volume | 10 |
Search more.